IN BRIEF: Synthomer to divest ‘capital-intensive’ Acrylate Monomers
Synthomer PLC - London-based developer of polymer chemicals - Agrees to divest the operating company of its Czech Republic-based Acrylate Monomers business, to German ‘private equity-style company’ Mutares SE & Co KGaA. Acrylate supplies acrylic acid and related monomers to European merchants. Synthomer says Acrylate supports some downstream needs, including as an acrylic monomer supplier for group companies and producing acrylic dispersions on its behalf, and that these arrangements will continue.
Divestment consideration comprises a cash generation sharing arrangement of up to €12 million over three years. Synthomer says Acrylate operates in highly cyclical markets and is one of its ‘more capital-intensive’ businesses, having needed an average of around €5 million in capital expenditure per year. The group designated Acrylate, its only remaining upstream asset, as non-core as part of a strategic review announced in 2022.
Synthomer Chief Executive Officer Michael Willome comments: ‘Today’s announcement is another important step in delivering our strategy to simplify our business and sharpen our focus on higher-margin, higher-growth speciality chemicals markets where we have strong and sustainable leadership positions...Mutares, as an experienced turnaround investor with a strong track record in transforming industrial businesses, is well-positioned to support Acrylate Monomers in its next phase of development.’
Current stock price: 110.18 pence
12-month change: up 0.9%
Copyright 2026 Alliance News Ltd. All Rights Reserved.